Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)

Clinical trial NCT02860130 · TERMINATED

Trial details

NCT number: NCT02860130
Sponsor: Vantive Health LLC
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Regional Citrate Anticoagulation (RCA)Continuous Renal Replacement Therapy (CRRT)Acute Kidney Injury

Start date: 2016-09-27
Primary completion: 2018-05-12
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.